Suppr超能文献

过度表达野生型人α-突触核蛋白的小鼠早期和进行性感觉运动异常。

Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

作者信息

Fleming Sheila M, Salcedo Jonathan, Fernagut Pierre-Olivier, Rockenstein Edward, Masliah Eliezer, Levine Michael S, Chesselet Marie-Françoise

机构信息

Department of Neurology, The Mental Retardation Research Center, The David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095-1769, USA.

出版信息

J Neurosci. 2004 Oct 20;24(42):9434-40. doi: 10.1523/JNEUROSCI.3080-04.2004.

Abstract

Accumulation of alpha-synuclein in brain is a hallmark of synucleinopathies, neurodegenerative diseases that include Parkinson's disease. Mice overexpressing alpha-synuclein under the Thy-1 promoter (ASO) show abnormal accumulation of alpha-synuclein in cortical and subcortical regions of the brain, including the substantia nigra. We examined the motor deficits in ASO mice with a battery of sensorimotor tests that are sensitive to alterations in the nigrostriatal dopaminergic system. Male wild-type and ASO mice were tested every 2 months for 8 months for motor performance and coordination on a challenging beam, inverted grid, and pole, sensorimotor deficits in an adhesive removal test, spontaneous activity in a cylinder, and gait. Fine motor skills were assessed by the ability to grasp cotton from a bin. ASO mice displayed significant impairments in motor performance and coordination and a reduction in spontaneous activity as early as 2 months of age. Motor performance and coordination impairments became progressively worse with age and sensorimotor deficits appeared at 6 months. Fine motor skills were altered at 4 months and worsened at 8 months. These data indicate that overexpression of alpha-synuclein induced an early and progressive behavioral phenotype that can be detected in multiple tests of sensorimotor function. These behavioral deficits provide a useful way to assess novel drug therapy in genetic models of synucleinopathies.

摘要

α-突触核蛋白在大脑中的积累是突触核蛋白病(包括帕金森病在内的神经退行性疾病)的一个标志。在Thy-1启动子(ASO)控制下过表达α-突触核蛋白的小鼠,其大脑皮质和皮质下区域(包括黑质)会出现α-突触核蛋白的异常积累。我们用一系列对黑质纹状体多巴胺能系统改变敏感的感觉运动测试,来检测ASO小鼠的运动缺陷。雄性野生型和ASO小鼠每2个月接受一次测试,持续8个月,测试内容包括在具有挑战性的横梁、倒置网格和杆子上的运动表现和协调性、粘胶去除试验中的感觉运动缺陷、圆柱体中的自发活动以及步态。精细运动技能通过从容器中抓取棉花的能力来评估。ASO小鼠早在2月龄时就表现出运动表现和协调性的显著受损以及自发活动的减少。运动表现和协调性受损随着年龄增长逐渐恶化,感觉运动缺陷在6月龄时出现。精细运动技能在4月龄时发生改变,并在8月龄时恶化。这些数据表明,α-突触核蛋白的过表达诱导了一种早期且渐进性的行为表型,这种表型可在多种感觉运动功能测试中被检测到。这些行为缺陷为评估突触核蛋白病遗传模型中的新型药物治疗提供了一种有用的方法。

相似文献

1
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.
J Neurosci. 2004 Oct 20;24(42):9434-40. doi: 10.1523/JNEUROSCI.3080-04.2004.
2
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.
Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.
3
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.
Neurotherapeutics. 2017 Oct;14(4):1107-1119. doi: 10.1007/s13311-017-0544-9.
6
The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.
Behav Brain Res. 2016 May 1;304:102-10. doi: 10.1016/j.bbr.2016.02.017. Epub 2016 Feb 12.
8
Alpha-synuclein and transgenic mouse models.
Neurobiol Dis. 2004 Nov;17(2):123-30. doi: 10.1016/j.nbd.2004.07.001.
9
Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
BMC Neurosci. 2017 Jan 31;18(1):22. doi: 10.1186/s12868-017-0341-8.
10
Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.
J Neurosci. 2003 Apr 15;23(8):3095-9. doi: 10.1523/JNEUROSCI.23-08-03095.2003.

引用本文的文献

1
Phenotype Differences Between ATP13A2 Heterozygous and Knockout Mice Across Aging.
Int J Mol Sci. 2025 Jul 22;26(15):7030. doi: 10.3390/ijms26157030.
2
3
Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy.
Nat Commun. 2025 May 1;16(1):4079. doi: 10.1038/s41467-025-59441-7.
6
Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease.
Front Aging Neurosci. 2024 Dec 23;16:1464706. doi: 10.3389/fnagi.2024.1464706. eCollection 2024.
8
Aging, Parkinson's Disease, and Models: What Are the Challenges?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.

本文引用的文献

1
Alpha-synuclein and transgenic mouse models.
Neurobiol Dis. 2004 Nov;17(2):123-30. doi: 10.1016/j.nbd.2004.07.001.
3
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Exp Neurol. 2003 Nov;184 Suppl 1:S68-79. doi: 10.1016/j.expneurol.2003.08.008.
4
alpha-Synuclein locus triplication causes Parkinson's disease.
Science. 2003 Oct 31;302(5646):841. doi: 10.1126/science.1090278.
6
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
J Biol Chem. 2003 Oct 31;278(44):43628-35. doi: 10.1074/jbc.M308947200. Epub 2003 Aug 20.
8
Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses.
Ann N Y Acad Sci. 2003 Jun;991:107-10. doi: 10.1111/j.1749-6632.2003.tb07468.x.
9
Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Brain Res Mol Brain Res. 2003 Jun 10;114(2):123-31. doi: 10.1016/s0169-328x(03)00162-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验